<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39356719</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>Sequential early-life viral infections modulate the microbiota and adaptive immune responses to systemic and mucosal vaccination.</ArticleTitle><Pagination><StartPage>e1012557</StartPage><MedlinePgn>e1012557</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1012557</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1012557</ELocationID><Abstract><AbstractText>Increasing evidence points to the microbial exposome as a critical factor in maturing and shaping the host immune system, thereby influencing responses to immune challenges such as infections or vaccines. To investigate the effect of early-life viral exposures on immune development and vaccine responses, we inoculated mice with six distinct viral pathogens in sequence beginning in the neonatal period, and then evaluated their immune signatures before and after intramuscular or intranasal vaccination against SARS-CoV-2. Sequential viral infection drove profound changes in all aspects of the immune system, including increasing circulating leukocytes, altering innate and adaptive immune cell lineages in tissues, and markedly influencing serum cytokine and total antibody levels. Beyond changes in the immune responses, these exposures also modulated the composition of the endogenous intestinal microbiota. Although sequentially-infected mice exhibited increased systemic immune activation and T cell responses after intramuscular and intranasal SARS-CoV-2 immunization, we observed decreased vaccine-induced antibody responses in these animals. These results suggest that early-life viral exposures are sufficient to diminish antibody responses to vaccination in mice, and highlight the potential importance of considering prior microbial exposures when investigating vaccine responses.</AbstractText><CopyrightInformation>Copyright: © 2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuhao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molleston</LastName><ForeName>Jerome M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovato</LastName><ForeName>Crystal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Jasmine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erickson</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bui</LastName><ForeName>Duyen</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Andrew H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingle</LastName><ForeName>Harshad</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Somya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nolan</LastName><ForeName>Lila S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Division of Newborn Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Ahmed O</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foster</LastName><ForeName>Lynne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diamond</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology &amp; Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldridge</LastName><ForeName>Megan T</ForeName><Initials>MT</Initials><Identifier Source="ORCID">0000-0002-7030-6131</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Edison Family Center for Genome Sciences &amp; Systems Biology, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>75N92020D00005</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI171831</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI141716</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI139314</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N93022D00005</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N99020D00005</GrantID><Acronym>OF</Acronym><Agency>ORFDO NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007163</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 OD024917</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N95020D00005</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI176290</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N93023D00005</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI157155</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 DK077653</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI106688</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI173360</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2023 Sep 01:2023.08.31.555772. doi: 10.1101/2023.08.31.555772</RefSource><PMID Version="1">37693434</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056704" MajorTopicYN="Y">Adaptive Immunity</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="N">Microbiota</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000281" MajorTopicYN="N">Administration, Intranasal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018928" MajorTopicYN="N">Immunity, Mucosal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>M.S.D. is a consultant for Inbios, Vir Biotechnology, Ocugen, Topspin Therapeutics, GlaxoSmithKline, Allen &amp; Overy LLP, Moderna, and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Vir Biotechnology, Emergent BioSolutions, and Moderna.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39356719</ArticleId><ArticleId IdType="pmc">PMC11472911</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1012557</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-24-01767</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Herati RS, Wherry EJ. What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Consideration of Strategies to Improve the Value of Animal Models. Cold Spring Harb Perspect Biol. 2018;10(4). Epub 20180402. doi: 10.1101/cshperspect.a031583 ; PubMed Central PMCID: PMC5880169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a031583</ArticleId><ArticleId IdType="pmc">PMC5880169</ArticleId><ArticleId IdType="pubmed">28348037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton SE, Badovinac VP, Beura LK, Pierson M, Jameson SC, Masopust D, et al.. New Insights into the Immune System Using Dirty Mice. J Immunol. 2020;205(1):3–11. doi: 10.4049/jimmunol.2000171 ; PubMed Central PMCID: PMC7316151.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000171</ArticleId><ArticleId IdType="pmc">PMC7316151</ArticleId><ArticleId IdType="pubmed">32571979</ArticleId></ArticleIdList></Reference><Reference><Citation>Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, et al.. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2013;110(9):3507–12. Epub 20130211. doi: 10.1073/pnas.1222878110 ; PubMed Central PMCID: PMC3587220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222878110</ArticleId><ArticleId IdType="pmc">PMC3587220</ArticleId><ArticleId IdType="pubmed">23401516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172(5):2731–8. doi: 10.4049/jimmunol.172.5.2731 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.172.5.2731</ArticleId><ArticleId IdType="pubmed">14978070</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins MA, Sjaastad FV, Pierson M, Kucaba TA, Swanson W, Staley C, et al.. Microbial Exposure Enhances Immunity to Pathogens Recognized by TLR2 but Increases Susceptibility to Cytokine Storm through TLR4 Sensitization. Cell Rep. 2019;28(7):1729–43 e5. doi: 10.1016/j.celrep.2019.07.028 ; PubMed Central PMCID: PMC6703181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.07.028</ArticleId><ArticleId IdType="pmc">PMC6703181</ArticleId><ArticleId IdType="pubmed">31412243</ArticleId></ArticleIdList></Reference><Reference><Citation>Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, et al.. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature. 2016;532(7600):512–6. Epub 2016/04/21. doi: 10.1038/nature17655 ; PubMed Central PMCID: PMC4871315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature17655</ArticleId><ArticleId IdType="pmc">PMC4871315</ArticleId><ArticleId IdType="pubmed">27096360</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust D, Sivula CP, Jameson SC. Of Mice, Dirty Mice, and Men: Using Mice To Understand Human Immunology. J Immunol. 2017;199(2):383–8. doi: 10.4049/jimmunol.1700453 ; PubMed Central PMCID: PMC5512602.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700453</ArticleId><ArticleId IdType="pmc">PMC5512602</ArticleId><ArticleId IdType="pubmed">28696328</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosshart SP, Herz J, Vassallo BG, Hunter A, Wall MK, Badger JH, et al.. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science. 2019;365(6452). Epub 20190801. doi: 10.1126/science.aaw4361 ; PubMed Central PMCID: PMC7377314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaw4361</ArticleId><ArticleId IdType="pmc">PMC7377314</ArticleId><ArticleId IdType="pubmed">31371577</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung F, Chen YH, Lin JD, Leung JM, McCauley C, Devlin JC, et al.. Altered Immunity of Laboratory Mice in the Natural Environment Is Associated with Fungal Colonization. Cell Host Microbe. 2020;27(5):809–22 e6. Epub 20200324. doi: 10.1016/j.chom.2020.02.015 ; PubMed Central PMCID: PMC7276265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.02.015</ArticleId><ArticleId IdType="pmc">PMC7276265</ArticleId><ArticleId IdType="pubmed">32209432</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese TA, Bi K, Kambal A, Filali-Mouhim A, Beura LK, Burger MC, et al.. Sequential Infection with Common Pathogens Promotes Human-like Immune Gene Expression and Altered Vaccine Response. Cell Host Microbe. 2016;19(5):713–9. Epub 20160420. doi: 10.1016/j.chom.2016.04.003 ; PubMed Central PMCID: PMC4896745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.04.003</ArticleId><ArticleId IdType="pmc">PMC4896745</ArticleId><ArticleId IdType="pubmed">27107939</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung JM, Budischak SA, Chung The H, Hansen C, Bowcutt R, Neill R, et al.. Rapid environmental effects on gut nematode susceptibility in rewilded mice. PLoS Biol. 2018;16(3):e2004108. Epub 20180308. doi: 10.1371/journal.pbio.2004108 ; PubMed Central PMCID: PMC5843147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2004108</ArticleId><ArticleId IdType="pmc">PMC5843147</ArticleId><ArticleId IdType="pubmed">29518091</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiege JK, Block KE, Pierson MJ, Nanda H, Shepherd FK, Mickelson CK, et al.. Mice with diverse microbial exposure histories as a model for preclinical vaccine testing. Cell Host Microbe. 2021. Epub 2021/11/04. doi: 10.1016/j.chom.2021.10.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.10.001</ArticleId><ArticleId IdType="pmc">PMC8665115</ArticleId><ArticleId IdType="pubmed">34731647</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Baldridge MT. Modelling human immune responses using microbial exposures in rodents. Nat Microbiol. 2023;8(3):363–6. doi: 10.1038/s41564-023-01334-w ; PubMed Central PMCID: PMC9992131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-023-01334-w</ArticleId><ArticleId IdType="pmc">PMC9992131</ArticleId><ArticleId IdType="pubmed">36797488</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiege JK, Langlois RA. Embracing the heterogeneity of natural viruses in mouse studies. J Gen Virol. 2022;103(6). doi: 10.1099/jgv.0.001758 ; PubMed Central PMCID: PMC10027023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001758</ArticleId><ArticleId IdType="pmc">PMC10027023</ArticleId><ArticleId IdType="pubmed">35737518</ArticleId></ArticleIdList></Reference><Reference><Citation>Fay EJ, Balla KM, Roach SN, Shepherd FK, Putri DS, Wiggen TD, et al.. Natural rodent model of viral transmission reveals biological features of virus population dynamics. J Exp Med. 2022;219(2). Epub 20211227. doi: 10.1084/jem.20211220 ; PubMed Central PMCID: PMC8713297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20211220</ArticleId><ArticleId IdType="pmc">PMC8713297</ArticleId><ArticleId IdType="pubmed">34958350</ArticleId></ArticleIdList></Reference><Reference><Citation>Midha A, Jarquin-Diaz VH, Ebner F, Lober U, Hayani R, Kundik A, et al.. Guts within guts: the microbiome of the intestinal helminth parasite Ascaris suum is derived but distinct from its host. Microbiome. 2022;10(1):229. Epub 20221216. doi: 10.1186/s40168-022-01399-5 ; PubMed Central PMCID: PMC9756626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-022-01399-5</ArticleId><ArticleId IdType="pmc">PMC9756626</ArticleId><ArticleId IdType="pubmed">36527132</ArticleId></ArticleIdList></Reference><Reference><Citation>Llinas-Caballero K, Caraballo L. Helminths and Bacterial Microbiota: The Interactions of Two of Humans’ "Old Friends". Int J Mol Sci. 2022;23(21). Epub 20221101. doi: 10.3390/ijms232113358 ; PubMed Central PMCID: PMC9658883.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232113358</ArticleId><ArticleId IdType="pmc">PMC9658883</ArticleId><ArticleId IdType="pubmed">36362143</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Gutierrez X, Moran P, Taboada B, Serrano-Vazquez A, Isa P, Rojas-Velazquez L, et al.. The fecal and oropharyngeal eukaryotic viromes of healthy infants during the first year of life are personal. Sci Rep. 2023;13(1):938. Epub 20230117. doi: 10.1038/s41598-022-26707-9 ; PubMed Central PMCID: PMC9845211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-26707-9</ArticleId><ArticleId IdType="pmc">PMC9845211</ArticleId><ArticleId IdType="pubmed">36650178</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng QY, Huynh KT, van Zuylen WJ, Craig ME, Rawlinson WD. Cytomegalovirus infection in day care centres: A systematic review and meta-analysis of prevalence of infection in children. Rev Med Virol. 2019;29(1):e2011. Epub 20181010. doi: 10.1002/rmv.2011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2011</ArticleId><ArticleId IdType="pubmed">30306730</ArticleId></ArticleIdList></Reference><Reference><Citation>de-The G, Day NE, Geser A, Lavoue MF, Ho JH, Simons MJ, et al.. Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study—a review. IARC Sci Publ (1971). 1975;(11 Pt 2):3–16.</Citation><ArticleIdList><ArticleId IdType="pubmed">191375</ArticleId></ArticleIdList></Reference><Reference><Citation>Farkas T, Fey B, Keller G, Martella V, Egyed L. Molecular detection of murine noroviruses in laboratory and wild mice. Vet Microbiol. 2012;160(3–4):463–7. Epub 20120613. doi: 10.1016/j.vetmic.2012.06.002 ; PubMed Central PMCID: PMC3469783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2012.06.002</ArticleId><ArticleId IdType="pmc">PMC3469783</ArticleId><ArticleId IdType="pubmed">22748629</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah MP, Hall AJ. Norovirus Illnesses in Children and Adolescents. Infect Dis Clin North Am. 2018;32(1):103–18. doi: 10.1016/j.idc.2017.11.004 ; PubMed Central PMCID: PMC6814392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2017.11.004</ArticleId><ArticleId IdType="pmc">PMC6814392</ArticleId><ArticleId IdType="pubmed">29406972</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebbelstrup Jensen B, Jokelainen P, Nielsen ACY, Franck KT, Rejkjaer Holm D, Schonning K, et al.. Children Attending Day Care Centers are a Year-round Reservoir of Gastrointestinal Viruses. Sci Rep. 2019;9(1):3286. Epub 20190301. doi: 10.1038/s41598-019-40077-9 ; PubMed Central PMCID: PMC6397223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-40077-9</ArticleId><ArticleId IdType="pmc">PMC6397223</ArticleId><ArticleId IdType="pubmed">30824842</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruf BR, Knuf M. The burden of seasonal and pandemic influenza in infants and children. Eur J Pediatr. 2014;173(3):265–76. Epub 20130510. doi: 10.1007/s00431-013-2023-6 ; PubMed Central PMCID: PMC3930829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-013-2023-6</ArticleId><ArticleId IdType="pmc">PMC3930829</ArticleId><ArticleId IdType="pubmed">23661234</ArticleId></ArticleIdList></Reference><Reference><Citation>El Guerche-Seblain C, Moureau A, Schiffler C, Dupuy M, Pepin S, Samson SI, et al.. Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysis of data from the placebo arm of a phase III efficacy trial. BMC Infect Dis. 2019;19(1):308. Epub 20190404. doi: 10.1186/s12879-019-3920-8 ; PubMed Central PMCID: PMC6449994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-3920-8</ArticleId><ArticleId IdType="pmc">PMC6449994</ArticleId><ArticleId IdType="pubmed">30947693</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita H, Yasuda M, Yamamoto M, Uchida R, Tanaka M, Ishida T, et al.. Prevalence of murine astrovirus in laboratory animal facilities in Japan. J Vet Med Sci. 2020;82(7):881–5. Epub 20200518. doi: 10.1292/jvms.20-0180 ; PubMed Central PMCID: PMC7399306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1292/jvms.20-0180</ArticleId><ArticleId IdType="pmc">PMC7399306</ArticleId><ArticleId IdType="pubmed">32418936</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong HS, Jeong A, Cheon DS. Epidemiology of astrovirus infection in children. Korean J Pediatr. 2012;55(3):77–82. Epub 20120316. doi: 10.3345/kjp.2012.55.3.77 ; PubMed Central PMCID: PMC3315622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2012.55.3.77</ArticleId><ArticleId IdType="pmc">PMC3315622</ArticleId><ArticleId IdType="pubmed">22474461</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha SK, Shrestha J, Andreassen AK, Strand TA, Dudman S, Dembinski JL. Genetic Diversity of Astrovirus in Children From a Birth Cohort in Nepal. Front Microbiol. 2020;11:588707. Epub 20210205. doi: 10.3389/fmicb.2020.588707 ; PubMed Central PMCID: PMC7893100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.588707</ArticleId><ArticleId IdType="pmc">PMC7893100</ArticleId><ArticleId IdType="pubmed">33613461</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer L, Moreni G, Wolthers KC, Pajkrt D. World-Wide Prevalence and Genotype Distribution of Enteroviruses. Viruses. 2021;13(3). Epub 20210308. doi: 10.3390/v13030434 ; PubMed Central PMCID: PMC7999254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030434</ArticleId><ArticleId IdType="pmc">PMC7999254</ArticleId><ArticleId IdType="pubmed">33800518</ArticleId></ArticleIdList></Reference><Reference><Citation>Prill MM, Dahl RM, Midgley CM, Chern SW, Lu X, Feikin DR, et al.. Severe Respiratory Illness Associated With Rhinovirus During the Enterovirus D68 Outbreak in the United States, August 2014-November 2014. Clin Infect Dis. 2018;66(10):1528–34. doi: 10.1093/cid/cix1034 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix1034</ArticleId><ArticleId IdType="pmc">PMC11305614</ArticleId><ArticleId IdType="pubmed">29186347</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldridge MT, Nice TJ, McCune BT, Yokoyama CC, Kambal A, Wheadon M, et al.. Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection. Science. 2015;347(6219):266–9. Epub 20141127. doi: 10.1126/science.1258025 ; PubMed Central PMCID: PMC4409937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1258025</ArticleId><ArticleId IdType="pmc">PMC4409937</ArticleId><ArticleId IdType="pubmed">25431490</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingle H, Hassan E, Gawron J, Mihi B, Li Y, Kennedy EA, et al.. Murine astrovirus tropism for goblet cells and enterocytes facilitates an IFN-lambda response in vivo and in enteroid cultures. Mucosal Immunol. 2021;14(3):751–61. Epub 20210305. doi: 10.1038/s41385-021-00387-6 ; PubMed Central PMCID: PMC8085034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00387-6</ArticleId><ArticleId IdType="pmc">PMC8085034</ArticleId><ArticleId IdType="pubmed">33674763</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z, Zou J, Zhang Z, Zhao X, Noriega J, Zhang B, et al.. Segmented Filamentous Bacteria Prevent and Cure Rotavirus Infection. Cell. 2019;179(3):644–58 e13. Epub 20191010. doi: 10.1016/j.cell.2019.09.028 ; PubMed Central PMCID: PMC7525827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.09.028</ArticleId><ArticleId IdType="pmc">PMC7525827</ArticleId><ArticleId IdType="pubmed">31607511</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhalech AH, Corn CM, Mangale V, Syed F, Condotta SA, Richer MJ, et al.. Testosterone Promotes the Intestinal Replication and Dissemination of Coxsackievirus B3 in an Oral Inoculation Mouse Model. J Virol. 2022;96(17):e0123222. Epub 20220829. doi: 10.1128/jvi.01232-22 ; PubMed Central PMCID: PMC9472648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01232-22</ArticleId><ArticleId IdType="pmc">PMC9472648</ArticleId><ArticleId IdType="pubmed">36037480</ArticleId></ArticleIdList></Reference><Reference><Citation>Langdon JM, Yates SC, Femnou LK, McCranor BJ, Cheadle C, Xue QL, et al.. Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation. Am J Hematol. 2014;89(5):470–9. Epub 20140224. doi: 10.1002/ajh.23670 ; PubMed Central PMCID: PMC4200395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.23670</ArticleId><ArticleId IdType="pmc">PMC4200395</ArticleId><ArticleId IdType="pubmed">24415655</ArticleId></ArticleIdList></Reference><Reference><Citation>Beura LK, Wijeyesinghe S, Thompson EA, Macchietto MG, Rosato PC, Pierson MJ, et al.. T Cells in Nonlymphoid Tissues Give Rise to Lymph-Node-Resident Memory T Cells. Immunity. 2018;48(2):327–38 e5. doi: 10.1016/j.immuni.2018.01.015 ; PubMed Central PMCID: PMC5828517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.01.015</ArticleId><ArticleId IdType="pmc">PMC5828517</ArticleId><ArticleId IdType="pubmed">29466758</ArticleId></ArticleIdList></Reference><Reference><Citation>Muleta KG, Ulmert I, Hamza KH, van Dijl S, Nakawesi J, Lahl K. Rotavirus-Induced Expansion of Antigen-Specific CD8 T Cells Does Not Require Signaling via TLR3, MyD88 or the Type I Interferon Receptor. Front Immunol. 2022;13:814491. Epub 20220407. doi: 10.3389/fimmu.2022.814491 ; PubMed Central PMCID: PMC9022177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.814491</ArticleId><ArticleId IdType="pmc">PMC9022177</ArticleId><ArticleId IdType="pubmed">35464475</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomov VT, Osborne LC, Dolfi DV, Sonnenberg GF, Monticelli LA, Mansfield K, et al.. Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses. J Virol. 2013;87(12):7015–31. Epub 20130417. doi: 10.1128/JVI.03389-12 ; PubMed Central PMCID: PMC3676130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03389-12</ArticleId><ArticleId IdType="pmc">PMC3676130</ArticleId><ArticleId IdType="pubmed">23596300</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Wen Y, Kelly SH, Chong AS, Collier JH. Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8(+) T cell responses. J Control Release. 2018;282:120–30. Epub 20180417. doi: 10.1016/j.jconrel.2018.04.031 ; PubMed Central PMCID: PMC6309200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2018.04.031</ArticleId><ArticleId IdType="pmc">PMC6309200</ArticleId><ArticleId IdType="pubmed">29673645</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomov VT, Palko O, Lau CW, Pattekar A, Sun Y, Tacheva R, et al.. Differentiation and Protective Capacity of Virus-Specific CD8(+) T Cells Suggest Murine Norovirus Persistence in an Immune-Privileged Enteric Niche. Immunity. 2017;47(4):723–38 e5. Epub 20171011. doi: 10.1016/j.immuni.2017.09.017 ; PubMed Central PMCID: PMC6077984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.09.017</ArticleId><ArticleId IdType="pmc">PMC6077984</ArticleId><ArticleId IdType="pubmed">29031786</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan AO, Kafai NM, Dmitriev IP, Fox JM, Smith BK, Harvey IB, et al.. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2. Cell. 2020;183(1):169–84 e13. Epub 20200819. doi: 10.1016/j.cell.2020.08.026 ; PubMed Central PMCID: PMC7437481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.026</ArticleId><ArticleId IdType="pmc">PMC7437481</ArticleId><ArticleId IdType="pubmed">32931734</ArticleId></ArticleIdList></Reference><Reference><Citation>Case JB, Rothlauf PW, Chen RE, Liu Z, Zhao H, Kim AS, et al.. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2. Cell Host Microbe. 2020;28(3):475–85 e5. Epub 20200703. doi: 10.1016/j.chom.2020.06.021 ; PubMed Central PMCID: PMC7332453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.06.021</ArticleId><ArticleId IdType="pmc">PMC7332453</ArticleId><ArticleId IdType="pubmed">32735849</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, et al.. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181(7):1489–501 e15. Epub 20200520. doi: 10.1016/j.cell.2020.05.015 ; PubMed Central PMCID: PMC7237901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7237901</ArticleId><ArticleId IdType="pubmed">32473127</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaya HI, Hagan T, Duraisingham SS, Lee EK, Kwissa M, Rouphael N, et al.. Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures. Immunity. 2015;43(6):1186–98. doi: 10.1016/j.immuni.2015.11.012 ; PubMed Central PMCID: PMC4859820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.11.012</ArticleId><ArticleId IdType="pmc">PMC4859820</ArticleId><ArticleId IdType="pubmed">26682988</ArticleId></ArticleIdList></Reference><Reference><Citation>Payton T, Girgenti D, Frenck RW, Patterson S, Love J, Razmpour A, et al.. Immunogenicity, safety and tolerability of 3 lots of 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in the United States. Pediatr Infect Dis J. 2013;32(8):871–80. doi: 10.1097/INF.0b013e3182906499 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3182906499</ArticleId><ArticleId IdType="pubmed">23584582</ArticleId></ArticleIdList></Reference><Reference><Citation>Barouch DH, Tomaka FL, Wegmann F, Stieh DJ, Alter G, Robb ML, et al.. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13–19). Lancet. 2018;392(10143):232–43. Epub 20180706. doi: 10.1016/S0140-6736(18)31364-3 ; PubMed Central PMCID: PMC6192527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)31364-3</ArticleId><ArticleId IdType="pmc">PMC6192527</ArticleId><ArticleId IdType="pubmed">30047376</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynn DJ, Benson SC, Lynn MA, Pulendran B. Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms. Nat Rev Immunol. 2022;22(1):33–46. Epub 20210517. doi: 10.1038/s41577-021-00554-7 ; PubMed Central PMCID: PMC8127454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00554-7</ArticleId><ArticleId IdType="pmc">PMC8127454</ArticleId><ArticleId IdType="pubmed">34002068</ArticleId></ArticleIdList></Reference><Reference><Citation>Dbaibo G, Amanullah A, Claeys C, Izu A, Jain VK, Kosalaraksa P, et al.. Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial. Pediatr Infect Dis J. 2020;39(1):e1–e10. doi: 10.1097/INF.0000000000002504 ; PubMed Central PMCID: PMC7004464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002504</ArticleId><ArticleId IdType="pmc">PMC7004464</ArticleId><ArticleId IdType="pubmed">31725115</ArticleId></ArticleIdList></Reference><Reference><Citation>Muyanja E, Ssemaganda A, Ngauv P, Cubas R, Perrin H, Srinivasan D, et al.. Immune activation alters cellular and humoral responses to yellow fever 17D vaccine. J Clin Invest. 2014;124(7):3147–58. Epub 20140609. doi: 10.1172/JCI75429 ; PubMed Central PMCID: PMC4071376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI75429</ArticleId><ArticleId IdType="pmc">PMC4071376</ArticleId><ArticleId IdType="pubmed">24911151</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasin C, Balelli I, Van Effelterre T, Bockstal V, Solforosi L, Prague M, et al.. Dynamics of the Humoral Immune Response to a Prime-Boost Ebola Vaccine: Quantification and Sources of Variation. J Virol. 2019;93(18). Epub 20190828. doi: 10.1128/JVI.00579-19 ; PubMed Central PMCID: PMC6714808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00579-19</ArticleId><ArticleId IdType="pmc">PMC6714808</ArticleId><ArticleId IdType="pubmed">31243126</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong SE, Olin A, Pulendran B. The Impact of the Microbiome on Immunity to Vaccination in Humans. Cell Host Microbe. 2020;28(2):169–79. doi: 10.1016/j.chom.2020.06.014 ; PubMed Central PMCID: PMC7422826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.06.014</ArticleId><ArticleId IdType="pmc">PMC7422826</ArticleId><ArticleId IdType="pubmed">32791110</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh JZ, Ravindran R, Chassaing B, Carvalho FA, Maddur MS, Bower M, et al.. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity. 2014;41(3):478–92. Epub 20140911. doi: 10.1016/j.immuni.2014.08.009 ; PubMed Central PMCID: PMC4169736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.08.009</ArticleId><ArticleId IdType="pmc">PMC4169736</ArticleId><ArticleId IdType="pubmed">25220212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagan T, Cortese M, Rouphael N, Boudreau C, Linde C, Maddur MS, et al.. Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans. Cell. 2019;178(6):1313–28 e13. doi: 10.1016/j.cell.2019.08.010 ; PubMed Central PMCID: PMC6750738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.08.010</ArticleId><ArticleId IdType="pmc">PMC6750738</ArticleId><ArticleId IdType="pubmed">31491384</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim AH, Armah G, Dennis F, Wang L, Rodgers R, Droit L, et al.. Enteric virome negatively affects seroconversion following oral rotavirus vaccination in a longitudinally sampled cohort of Ghanaian infants. Cell Host Microbe. 2022;30(1):110–23 e5. Epub 20211220. doi: 10.1016/j.chom.2021.12.002 ; PubMed Central PMCID: PMC8763403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.12.002</ArticleId><ArticleId IdType="pmc">PMC8763403</ArticleId><ArticleId IdType="pubmed">34932985</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris VC, Haak BW, Handley SA, Jiang B, Velasquez DE, Hykes BL Jr., et al.. Effect of Antibiotic-Mediated Microbiome Modulation on Rotavirus Vaccine Immunogenicity: A Human, Randomized-Control Proof-of-Concept Trial. Cell Host Microbe. 2018;24(2):197–207 e4. doi: 10.1016/j.chom.2018.07.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.07.005</ArticleId><ArticleId IdType="pubmed">30092197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng SC, Peng Y, Zhang L, Mok CK, Zhao S, Li A, et al.. Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. Gut. 2022;71(6):1106–16. Epub 20220209. doi: 10.1136/gutjnl-2021-326563 ; PubMed Central PMCID: PMC8844967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-326563</ArticleId><ArticleId IdType="pmc">PMC8844967</ArticleId><ArticleId IdType="pubmed">35140064</ArticleId></ArticleIdList></Reference><Reference><Citation>Akatsu H, Iwabuchi N, Xiao JZ, Matsuyama Z, Kurihara R, Okuda K, et al.. Clinical effects of probiotic Bifidobacterium longum BB536 on immune function and intestinal microbiota in elderly patients receiving enteral tube feeding. JPEN J Parenter Enteral Nutr. 2013;37(5):631–40. Epub 20121127. doi: 10.1177/0148607112467819 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607112467819</ArticleId><ArticleId IdType="pubmed">23192454</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu BB, Yang Y, Xu X, Wang WP. Effects of Bifidobacterium supplementation on intestinal microbiota composition and the immune response in healthy infants. World J Pediatr. 2016;12(2):177–82. Epub 20150406. doi: 10.1007/s12519-015-0025-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-015-0025-3</ArticleId><ArticleId IdType="pubmed">25846071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch M, Mendez M, Perez M, Farran A, Fuentes MC, Cune J. Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly. Nutr Hosp. 2012;27(2):504–9. doi: 10.1590/S0212-16112012000200023 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0212-16112012000200023</ArticleId><ArticleId IdType="pubmed">22732975</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, et al.. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature. 2007;447(7142):326–9. doi: 10.1038/nature05762 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05762</ArticleId><ArticleId IdType="pubmed">17507983</ArticleId></ArticleIdList></Reference><Reference><Citation>Stelekati E, Wherry EJ. Chronic bystander infections and immunity to unrelated antigens. Cell Host Microbe. 2012;12(4):458–69. doi: 10.1016/j.chom.2012.10.001 ; PubMed Central PMCID: PMC3617576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.10.001</ArticleId><ArticleId IdType="pmc">PMC3617576</ArticleId><ArticleId IdType="pubmed">23084915</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan AO, Shrihari S, Gorman MJ, Ying B, Yuan D, Raju S, et al.. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice. Cell Rep. 2021;36(4):109452. Epub 20210710. doi: 10.1016/j.celrep.2021.109452 ; PubMed Central PMCID: PMC8270739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109452</ArticleId><ArticleId IdType="pmc">PMC8270739</ArticleId><ArticleId IdType="pubmed">34289385</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al.. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271–80 e8. Epub 20200305. doi: 10.1016/j.cell.2020.02.052 ; PubMed Central PMCID: PMC7102627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et al.. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4516–22. Epub 2010/06/11. doi: 10.1073/pnas.1000080107 ; PubMed Central PMCID: PMC3063599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1000080107</ArticleId><ArticleId IdType="pmc">PMC3063599</ArticleId><ArticleId IdType="pubmed">20534432</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581–3. Epub 2016/05/24. doi: 10.1038/nmeth.3869 ; PubMed Central PMCID: PMC4927377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3869</ArticleId><ArticleId IdType="pmc">PMC4927377</ArticleId><ArticleId IdType="pubmed">27214047</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, et al.. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 2014;42(Database issue):D633–42. Epub 2013/11/30. doi: 10.1093/nar/gkt1244 ; PubMed Central PMCID: PMC3965039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1244</ArticleId><ArticleId IdType="pmc">PMC3965039</ArticleId><ArticleId IdType="pubmed">24288368</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013;8(4):e61217. Epub 2013/05/01. doi: 10.1371/journal.pone.0061217 ; PubMed Central PMCID: PMC3632530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0061217</ArticleId><ArticleId IdType="pmc">PMC3632530</ArticleId><ArticleId IdType="pubmed">23630581</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Zhan L, Tang W, Wang Q, Dai Z, Zhou L, et al.. MicrobiotaProcess: A comprehensive R package for deep mining microbiome. Innovation (Camb). 2023;4(2):100388. Epub 20230202. doi: 10.1016/j.xinn.2023.100388 ; PubMed Central PMCID: PMC9988672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xinn.2023.100388</ArticleId><ArticleId IdType="pmc">PMC9988672</ArticleId><ArticleId IdType="pubmed">36895758</ArticleId></ArticleIdList></Reference><Reference><Citation>Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al.. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. Epub 2011/06/28. doi: 10.1186/gb-2011-12-6-r60 ; PubMed Central PMCID: PMC3218848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2011-12-6-r60</ArticleId><ArticleId IdType="pmc">PMC3218848</ArticleId><ArticleId IdType="pubmed">21702898</ArticleId></ArticleIdList></Reference><Reference><Citation>Baert L, Wobus CE, Van Coillie E, Thackray LB, Debevere J, Uyttendaele M. Detection of murine norovirus 1 by using plaque assay, transfection assay, and real-time reverse transcription-PCR before and after heat exposure. Appl Environ Microbiol. 2008;74(2):543–6. Epub 2007/11/21. doi: 10.1128/AEM.01039-07 ; PubMed Central PMCID: PMC2223245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.01039-07</ArticleId><ArticleId IdType="pmc">PMC2223245</ArticleId><ArticleId IdType="pubmed">18024676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingle H, Lee S, Ai T, Orvedahl A, Rodgers R, Zhao G, et al.. Viral complementation of immunodeficiency confers protection against enteric pathogens via interferon-lambda. Nat Microbiol. 2019;4(7):1120–8. Epub 2019/04/03. doi: 10.1038/s41564-019-0416-7 ; PubMed Central PMCID: PMC6588490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0416-7</ArticleId><ArticleId IdType="pmc">PMC6588490</ArticleId><ArticleId IdType="pubmed">30936486</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldridge MT, Lee S, Brown JJ, McAllister N, Urbanek K, Dermody TS, et al.. Expression of Ifnlr1 on intestinal epithelial cells is critical to the antiviral effects of IFN-lambda against norovirus and reovirus. J Virol. 2017. doi: 10.1128/JVI.02079-16 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02079-16</ArticleId><ArticleId IdType="pmc">PMC5355594</ArticleId><ArticleId IdType="pubmed">28077655</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazawa M. fmsb: Functions for medical statistics book with some demographic data. R package version 06. 2018;3(3).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>